- Endo International Plc (NASDAQ:ENDP) initiated negotiations with its lenders and senior bondholders regarding a possible reorganization of more than $8 billion of its debt, the Wall Street Journal reported, citing people familiar with the matter.
- Lenders began talks after the company reported disappointing earnings early this month for 1Q 2022, driven by the loss of exclusive rights to a key drug.
- Related: Endo Shares Plummet On Decreasing Sales, Wider Loss; Outlook Lagging Consensus.
- The lawyers representing lenders have already started the confidential discussions with the company.
- Endo is already battling roughly 3,500 lawsuits over its role in the opioid epidemic.
- Also Read: JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters.
- Price Action: ENDP shares are down 48.1% at $0.60 during the market session on the last check Wednesday.
Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
What Is Happening With Endo Shares Today
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks